Showing 18 of 58 recruiting trials for “Huntington's Disease”
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
RecruitingNCT06460142 ↗
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
👨⚕️ Valentin S. Schäfer, Univ. Prof., Department of Rheumatology and Clinical Immunology, University Hospital Bonn📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06011512 ↗
Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.
👨⚕️ Salome Kristensen, MD, PhD, Aalborg University Hospital📍 1 site📅 Started Aug 2023View details ↗
Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
👨⚕️ Erin Stimming, MD, The University of Texas Health Science Center, Houston📍 1 site📅 Started Jun 2023View details ↗
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
👨⚕️ Merry Mazmanian, Dr., Santé Arménie French - Armenian Academic Research Organization FAARO📍 6 sites📅 Started Jun 2023View details ↗
Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease
👨⚕️ Pablo Mir Rivera, MD/PhD, Institute of Biomedicine of Seville (IBiS)📍 3 sites📅 Started Apr 2023View details ↗
Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
RecruitingNCT06203106 ↗
NYSCF Scientific Discovery Biobank
👨⚕️ Laura Andres-Martin, PhD, New York Stem Cell Foundation Research Institute📍 1 site📅 Started Nov 2022View details ↗
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
👨⚕️ Ulla Feldt-Rasmussen, Professor, Rigshospitalet, Denmark📍 3 sites📅 Started Jun 2022View details ↗
RecruitingNCT05479448 ↗
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
👨⚕️ Thomas Daikeler, Prof. Dr. med., Department of Rheumatology University Hospital Basel📍 1 site📅 Started Jun 2022View details ↗
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
RecruitingNCT03434548 ↗
IMarkHD: in Vivo Longitudinal Imaging of HD Pathology
Abatacept for the Treatment of Giant Cell Arteritis
RecruitingNCT04664465 ↗
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
RecruitingNCT05865054 ↗
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease
RecruitingNCT04102930 ↗
Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
← PreviousPage 3 of 3
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →